1. Home
  2. CRVS vs NEWP Comparison

CRVS vs NEWP Comparison

Compare CRVS & NEWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • NEWP
  • Stock Information
  • Founded
  • CRVS 2014
  • NEWP 1972
  • Country
  • CRVS United States
  • NEWP Canada
  • Employees
  • CRVS N/A
  • NEWP N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • NEWP
  • Sector
  • CRVS Health Care
  • NEWP
  • Exchange
  • CRVS Nasdaq
  • NEWP Nasdaq
  • Market Cap
  • CRVS 305.4M
  • NEWP 259.4M
  • IPO Year
  • CRVS 2016
  • NEWP N/A
  • Fundamental
  • Price
  • CRVS $4.17
  • NEWP $1.44
  • Analyst Decision
  • CRVS Strong Buy
  • NEWP
  • Analyst Count
  • CRVS 4
  • NEWP 0
  • Target Price
  • CRVS $15.00
  • NEWP N/A
  • AVG Volume (30 Days)
  • CRVS 437.5K
  • NEWP 287.1K
  • Earning Date
  • CRVS 08-12-2025
  • NEWP 09-23-2025
  • Dividend Yield
  • CRVS N/A
  • NEWP N/A
  • EPS Growth
  • CRVS N/A
  • NEWP N/A
  • EPS
  • CRVS N/A
  • NEWP N/A
  • Revenue
  • CRVS N/A
  • NEWP N/A
  • Revenue This Year
  • CRVS N/A
  • NEWP N/A
  • Revenue Next Year
  • CRVS N/A
  • NEWP N/A
  • P/E Ratio
  • CRVS N/A
  • NEWP N/A
  • Revenue Growth
  • CRVS N/A
  • NEWP N/A
  • 52 Week Low
  • CRVS $2.47
  • NEWP $0.93
  • 52 Week High
  • CRVS $10.00
  • NEWP $2.05
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 46.72
  • NEWP 38.48
  • Support Level
  • CRVS $4.58
  • NEWP $1.61
  • Resistance Level
  • CRVS $4.98
  • NEWP $1.71
  • Average True Range (ATR)
  • CRVS 0.23
  • NEWP 0.11
  • MACD
  • CRVS -0.02
  • NEWP -0.04
  • Stochastic Oscillator
  • CRVS 8.52
  • NEWP 7.76

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About NEWP New Pacific Metals Corp.

New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.

Share on Social Networks: